A research group led by Hisashi Arase (IFReC/RIMD/the Center for Infectious Diseases, Osaka University) discovered both neutralizing antibodies that protect against infection as well as infection-enhancing antibodies that increase infectivity are produced after infection with SARS-CoV-2 by analyzing antibodies derived from COVID-19 patients.

SARS-CoV-2 infectivity is enhanced upon antibody binding to NTD. (credit: Osaka University)

Commentary(PDF)


Article (External Link)

Contact:

Hisashi Arase (Immunochemistry)

+81-6-6879-8291
arasebiken.osaka-u.ac.jp
WPI Osaka University Immunology Frontier Research Center